Global Viral Vector Production (Research-use) Market Research Report 2024(Status and Outlook)

Global Viral Vector Production (Research-use) Market Research Report 2024(Status and Outlook)



Report Overview:

Viral vectors are increasingly being employed in ongoing clinical trials owing to their efficiency in gene delivery. Significant advancements in delivery vectors that have resulted in the increased therapeutic efficacy of such vectors for gene delivery are driving the market for viral vector production (research-use). Amongst all viral vectors, lentivirus, adeno-associated virus, and adenovirus are the most used vectors across research settings.

The Global Viral Vector Production (Research-use) Market Size was estimated at USD 1302.72 million in 2023 and is projected to reach USD 3662.27 million by 2029, exhibiting a CAGR of 18.80% during the forecast period.

This report provides a deep insight into the global Viral Vector Production (Research-use) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Vector Production (Research-use) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Vector Production (Research-use) market in any manner.

Global Viral Vector Production (Research-use) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck KGaA

Lonza

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

Cobra Biologics Ltd.

Thermo Fisher Scientific

Waisman Biomanufacturing

Genezen

YPOSKESI

Advanced BioScience Laboratories, Inc. (ABL, Inc.)

Novasep Holding S.A.S

Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)

Vigene Biosciences, Inc.

General Electric Company (GE Healthcare)

CEVEC Pharmaceuticals GmbH

Batavia Biosciences B.V.

Biovion oy

Wuxi AppTec Co., Ltd.

VGXI, Inc.

Catalent Inc.

Miltenyi Biotec GmbH

SIRION Biotech GmbH

Virovek Incorporation

BioNTech IMFS GmbH

VIVEbiotech S.L.

Creative Biogene

Vibalogics GmbH

Takara Bio.

Cell and Gene Therapy Catapult

BlueBird Bio

Addgene, Inc.

Aldevron, L.L.C.

Audentes Therapeutics

BioMarin Pharmaceutical

RegenxBio, Inc.

Market Segmentation (by Type)

Adeno-associated virus (AAV)

Lentivirus

Adenovirus

Retrovirus

Others

Market Segmentation (by Application)

Cell & Gene Therapy Development

Vaccine Development

Biopharmaceutical and Pharmaceutical Discovery

Biomedical Research

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Viral Vector Production (Research-use) Market

Overview of the regional outlook of the Viral Vector Production (Research-use) Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector Production (Research-use) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Viral Vector Production (Research-use)
1.2 Key Market Segments
1.2.1 Viral Vector Production (Research-use) Segment by Type
1.2.2 Viral Vector Production (Research-use) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Viral Vector Production (Research-use) Market Overview
2.1 Global Market Overview
2.1.1 Global Viral Vector Production (Research-use) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Vector Production (Research-use) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Viral Vector Production (Research-use) Market Competitive Landscape
3.1 Global Viral Vector Production (Research-use) Sales by Manufacturers (2019-2024)
3.2 Global Viral Vector Production (Research-use) Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Vector Production (Research-use) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Vector Production (Research-use) Sales Sites, Area Served, Product Type
3.6 Viral Vector Production (Research-use) Market Competitive Situation and Trends
3.6.1 Viral Vector Production (Research-use) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Vector Production (Research-use) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Viral Vector Production (Research-use) Industry Chain Analysis
4.1 Viral Vector Production (Research-use) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Viral Vector Production (Research-use) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Viral Vector Production (Research-use) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector Production (Research-use) Sales Market Share by Type (2019-2024)
6.3 Global Viral Vector Production (Research-use) Market Size Market Share by Type (2019-2024)
6.4 Global Viral Vector Production (Research-use) Price by Type (2019-2024)
7 Viral Vector Production (Research-use) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector Production (Research-use) Market Sales by Application (2019-2024)
7.3 Global Viral Vector Production (Research-use) Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Vector Production (Research-use) Sales Growth Rate by Application (2019-2024)
8 Viral Vector Production (Research-use) Market Segmentation by Region
8.1 Global Viral Vector Production (Research-use) Sales by Region
8.1.1 Global Viral Vector Production (Research-use) Sales by Region
8.1.2 Global Viral Vector Production (Research-use) Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Vector Production (Research-use) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vector Production (Research-use) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vector Production (Research-use) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vector Production (Research-use) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vector Production (Research-use) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck KGaA
9.1.1 Merck KGaA Viral Vector Production (Research-use) Basic Information
9.1.2 Merck KGaA Viral Vector Production (Research-use) Product Overview
9.1.3 Merck KGaA Viral Vector Production (Research-use) Product Market Performance
9.1.4 Merck KGaA Business Overview
9.1.5 Merck KGaA Viral Vector Production (Research-use) SWOT Analysis
9.1.6 Merck KGaA Recent Developments
9.2 Lonza
9.2.1 Lonza Viral Vector Production (Research-use) Basic Information
9.2.2 Lonza Viral Vector Production (Research-use) Product Overview
9.2.3 Lonza Viral Vector Production (Research-use) Product Market Performance
9.2.4 Lonza Business Overview
9.2.5 Lonza Viral Vector Production (Research-use) SWOT Analysis
9.2.6 Lonza Recent Developments
9.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
9.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Basic Information
9.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Overview
9.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Market Performance
9.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) SWOT Analysis
9.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
9.3.6 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
9.4 Cobra Biologics Ltd.
9.4.1 Cobra Biologics Ltd. Viral Vector Production (Research-use) Basic Information
9.4.2 Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Overview
9.4.3 Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Market Performance
9.4.4 Cobra Biologics Ltd. Business Overview
9.4.5 Cobra Biologics Ltd. Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Viral Vector Production (Research-use) Basic Information
9.5.2 Thermo Fisher Scientific Viral Vector Production (Research-use) Product Overview
9.5.3 Thermo Fisher Scientific Viral Vector Production (Research-use) Product Market Performance
9.5.4 Thermo Fisher Scientific Business Overview
9.5.5 Thermo Fisher Scientific Recent Developments
9.6 Waisman Biomanufacturing
9.6.1 Waisman Biomanufacturing Viral Vector Production (Research-use) Basic Information
9.6.2 Waisman Biomanufacturing Viral Vector Production (Research-use) Product Overview
9.6.3 Waisman Biomanufacturing Viral Vector Production (Research-use) Product Market Performance
9.6.4 Waisman Biomanufacturing Business Overview
9.6.5 Waisman Biomanufacturing Recent Developments
9.7 Genezen
9.7.1 Genezen Viral Vector Production (Research-use) Basic Information
9.7.2 Genezen Viral Vector Production (Research-use) Product Overview
9.7.3 Genezen Viral Vector Production (Research-use) Product Market Performance
9.7.4 Genezen Business Overview
9.7.5 Genezen Recent Developments
9.8 YPOSKESI
9.8.1 YPOSKESI Viral Vector Production (Research-use) Basic Information
9.8.2 YPOSKESI Viral Vector Production (Research-use) Product Overview
9.8.3 YPOSKESI Viral Vector Production (Research-use) Product Market Performance
9.8.4 YPOSKESI Business Overview
9.8.5 YPOSKESI Recent Developments
9.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
9.9.1 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Basic Information
9.9.2 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Overview
9.9.3 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Market Performance
9.9.4 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
9.9.5 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Developments
9.10 Novasep Holding S.A.S
9.10.1 Novasep Holding S.A.S Viral Vector Production (Research-use) Basic Information
9.10.2 Novasep Holding S.A.S Viral Vector Production (Research-use) Product Overview
9.10.3 Novasep Holding S.A.S Viral Vector Production (Research-use) Product Market Performance
9.10.4 Novasep Holding S.A.S Business Overview
9.10.5 Novasep Holding S.A.S Recent Developments
9.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
9.11.1 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Basic Information
9.11.2 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Overview
9.11.3 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Market Performance
9.11.4 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
9.11.5 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Developments
9.12 Vigene Biosciences, Inc.
9.12.1 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Basic Information
9.12.2 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Overview
9.12.3 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Market Performance
9.12.4 Vigene Biosciences, Inc. Business Overview
9.12.5 Vigene Biosciences, Inc. Recent Developments
9.13 General Electric Company (GE Healthcare)
9.13.1 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Basic Information
9.13.2 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Overview
9.13.3 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Market Performance
9.13.4 General Electric Company (GE Healthcare) Business Overview
9.13.5 General Electric Company (GE Healthcare) Recent Developments
9.14 CEVEC Pharmaceuticals GmbH
9.14.1 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Basic Information
9.14.2 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Overview
9.14.3 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Market Performance
9.14.4 CEVEC Pharmaceuticals GmbH Business Overview
9.14.5 CEVEC Pharmaceuticals GmbH Recent Developments
9.15 Batavia Biosciences B.V.
9.15.1 Batavia Biosciences B.V. Viral Vector Production (Research-use) Basic Information
9.15.2 Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Overview
9.15.3 Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Market Performance
9.15.4 Batavia Biosciences B.V. Business Overview
9.15.5 Batavia Biosciences B.V. Recent Developments
9.16 Biovion oy
9.16.1 Biovion oy Viral Vector Production (Research-use) Basic Information
9.16.2 Biovion oy Viral Vector Production (Research-use) Product Overview
9.16.3 Biovion oy Viral Vector Production (Research-use) Product Market Performance
9.16.4 Biovion oy Business Overview
9.16.5 Biovion oy Recent Developments
9.17 Wuxi AppTec Co., Ltd.
9.17.1 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Basic Information
9.17.2 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Overview
9.17.3 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Market Performance
9.17.4 Wuxi AppTec Co., Ltd. Business Overview
9.17.5 Wuxi AppTec Co., Ltd. Recent Developments
9.18 VGXI, Inc.
9.18.1 VGXI, Inc. Viral Vector Production (Research-use) Basic Information
9.18.2 VGXI, Inc. Viral Vector Production (Research-use) Product Overview
9.18.3 VGXI, Inc. Viral Vector Production (Research-use) Product Market Performance
9.18.4 VGXI, Inc. Business Overview
9.18.5 VGXI, Inc. Recent Developments
9.19 Catalent Inc.
9.19.1 Catalent Inc. Viral Vector Production (Research-use) Basic Information
9.19.2 Catalent Inc. Viral Vector Production (Research-use) Product Overview
9.19.3 Catalent Inc. Viral Vector Production (Research-use) Product Market Performance
9.19.4 Catalent Inc. Business Overview
9.19.5 Catalent Inc. Recent Developments
9.20 Miltenyi Biotec GmbH
9.20.1 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Basic Information
9.20.2 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Overview
9.20.3 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Market Performance
9.20.4 Miltenyi Biotec GmbH Business Overview
9.20.5 Miltenyi Biotec GmbH Recent Developments
9.21 SIRION Biotech GmbH
9.21.1 SIRION Biotech GmbH Viral Vector Production (Research-use) Basic Information
9.21.2 SIRION Biotech GmbH Viral Vector Production (Research-use) Product Overview
9.21.3 SIRION Biotech GmbH Viral Vector Production (Research-use) Product Market Performance
9.21.4 SIRION Biotech GmbH Business Overview
9.21.5 SIRION Biotech GmbH Recent Developments
9.22 Virovek Incorporation
9.22.1 Virovek Incorporation Viral Vector Production (Research-use) Basic Information
9.22.2 Virovek Incorporation Viral Vector Production (Research-use) Product Overview
9.22.3 Virovek Incorporation Viral Vector Production (Research-use) Product Market Performance
9.22.4 Virovek Incorporation Business Overview
9.22.5 Virovek Incorporation Recent Developments
9.23 BioNTech IMFS GmbH
9.23.1 BioNTech IMFS GmbH Viral Vector Production (Research-use) Basic Information
9.23.2 BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Overview
9.23.3 BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Market Performance
9.23.4 BioNTech IMFS GmbH Business Overview
9.23.5 BioNTech IMFS GmbH Recent Developments
9.24 VIVEbiotech S.L.
9.24.1 VIVEbiotech S.L. Viral Vector Production (Research-use) Basic Information
9.24.2 VIVEbiotech S.L. Viral Vector Production (Research-use) Product Overview
9.24.3 VIVEbiotech S.L. Viral Vector Production (Research-use) Product Market Performance
9.24.4 VIVEbiotech S.L. Business Overview
9.24.5 VIVEbiotech S.L. Recent Developments
9.25 Creative Biogene
9.25.1 Creative Biogene Viral Vector Production (Research-use) Basic Information
9.25.2 Creative Biogene Viral Vector Production (Research-use) Product Overview
9.25.3 Creative Biogene Viral Vector Production (Research-use) Product Market Performance
9.25.4 Creative Biogene Business Overview
9.25.5 Creative Biogene Recent Developments
9.26 Vibalogics GmbH
9.26.1 Vibalogics GmbH Viral Vector Production (Research-use) Basic Information
9.26.2 Vibalogics GmbH Viral Vector Production (Research-use) Product Overview
9.26.3 Vibalogics GmbH Viral Vector Production (Research-use) Product Market Performance
9.26.4 Vibalogics GmbH Business Overview
9.26.5 Vibalogics GmbH Recent Developments
9.27 Takara Bio.
9.27.1 Takara Bio. Viral Vector Production (Research-use) Basic Information
9.27.2 Takara Bio. Viral Vector Production (Research-use) Product Overview
9.27.3 Takara Bio. Viral Vector Production (Research-use) Product Market Performance
9.27.4 Takara Bio. Business Overview
9.27.5 Takara Bio. Recent Developments
9.28 Cell and Gene Therapy Catapult
9.28.1 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Basic Information
9.28.2 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Overview
9.28.3 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Market Performance
9.28.4 Cell and Gene Therapy Catapult Business Overview
9.28.5 Cell and Gene Therapy Catapult Recent Developments
9.29 BlueBird Bio
9.29.1 BlueBird Bio Viral Vector Production (Research-use) Basic Information
9.29.2 BlueBird Bio Viral Vector Production (Research-use) Product Overview
9.29.3 BlueBird Bio Viral Vector Production (Research-use) Product Market Performance
9.29.4 BlueBird Bio Business Overview
9.29.5 BlueBird Bio Recent Developments
9.30 Addgene, Inc.
9.30.1 Addgene, Inc. Viral Vector Production (Research-use) Basic Information
9.30.2 Addgene, Inc. Viral Vector Production (Research-use) Product Overview
9.30.3 Addgene, Inc. Viral Vector Production (Research-use) Product Market Performance
9.30.4 Addgene, Inc. Business Overview
9.30.5 Addgene, Inc. Recent Developments
10 Viral Vector Production (Research-use) Market Forecast by Region
10.1 Global Viral Vector Production (Research-use) Market Size Forecast
10.2 Global Viral Vector Production (Research-use) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vector Production (Research-use) Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vector Production (Research-use) Market Size Forecast by Region
10.2.4 South America Viral Vector Production (Research-use) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector Production (Research-use) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Viral Vector Production (Research-use) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Vector Production (Research-use) by Type (2025-2030)
11.1.2 Global Viral Vector Production (Research-use) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Vector Production (Research-use) by Type (2025-2030)
11.2 Global Viral Vector Production (Research-use) Market Forecast by Application (2025-2030)
11.2.1 Global Viral Vector Production (Research-use) Sales (K Units) Forecast by Application
11.2.2 Global Viral Vector Production (Research-use) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings